Atai Life Sciences EBITDA 2020-2024 | ATAI

Atai Life Sciences ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Atai Life Sciences Annual EBITDA
(Millions of US $)
2023 $-125
2022 $-145
2021 $-136
2020 $-104
2019 $-18
Atai Life Sciences Quarterly EBITDA
(Millions of US $)
2024-09-30 $-23
2024-06-30 $-26
2024-03-31 $-24
2023-12-31 $-33
2023-09-30 $-27
2023-06-30 $-32
2023-03-31 $-33
2022-12-31 $-38
2022-09-30 $-38
2022-06-30 $-35
2022-03-31 $-33
2021-12-31 $-45
2021-09-30 $-33
2021-06-30 $-61
2021-03-31 $4
2020-12-31 $-87
2020-09-30 $-7
2020-06-30 $-6
2020-03-31 $-4
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.270B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $18.259B 18.51
DaVita (DVA) United States $13.572B 17.55
Encompass Health (EHC) United States $10.188B 24.02
Chemed (CHE) United States $8.593B 26.41
Elanco Animal Health (ELAN) United States $6.605B 15.72
RadNet (RDNT) United States $6.073B 134.49
Option Care Health (OPCH) United States $3.936B 18.65
Amedisys (AMED) United States $2.969B 21.13
LifeStance Health (LFST) United States $2.832B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.254B 26.45
U.S Physical Therapy (USPH) United States $1.477B 38.82
Aveanna Healthcare Holdings (AVAH) United States $1.128B 0.00
Pennant (PNTG) United States $1.070B 43.25
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00